BREZTRI 4.8 ug/1 (Budesonide, Glycopyrrolate, and Formoterol Fumarate AEROSOL, METERED) 4.8 ug/1

BREZTRI 4.8 ug/1 is a combination inhaler containing budesonide, glycopyrrolate, and formoterol fumarate. It is used for respiratory conditions like COPD and asthma. This metered aerosol inhaler is designed for easy inhalation.

Strength

4.8 ug/1

Pack Size

28 AEROSOL, METERED in 1 INHALER (0310-4616-39)

Manufacturer / TM Owner

AstraZeneca Pharmaceuticals LP

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

BREZTRI 4.8 ug/1 is primarily used for the maintenance treatment of chronic obstructive pulmonary disease (COPD) and asthma. The combination of budesonide, glycopyrrolate, and formoterol fumarate works to reduce inflammation and improve breathing. This inhaler is often prescribed to manage symptoms such as wheezing, shortness of breath, and coughing. It is important to consult a healthcare provider to determine if this medication is suitable for your specific condition.

Side Effects

Common effects of BREZTRI 4.8 ug/1 may include throat irritation, hoarseness, and dry mouth. Some users may experience headaches or tremors. These effects are generally mild and temporary. If you experience severe or persistent side effects, it is advisable to seek medical attention.

Precautions & Warnings

BREZTRI 4.8 ug/1 should be used as directed by a healthcare provider. It is important to follow the prescribed dosage and administration instructions. This inhaler should be stored at room temperature and kept away from moisture and heat. Always inform your healthcare provider about any other medications you are taking to avoid potential interactions.

Avoid Interactions

BREZTRI 4.8 ug/1 may interact with other medications, including beta-blockers, diuretics, and certain antidepressants. It is important to discuss all your current medications with your healthcare provider to avoid potential interactions. Additionally, avoid using this inhaler with other long-acting beta-agonists unless directed by a healthcare professional.

Frequently Asked Questions

BREZTRI 4.8 ug/1 is used for the maintenance treatment of COPD and asthma. It helps to reduce inflammation and improve breathing.

Follow the instructions provided by your healthcare provider. Typically, you will inhale the medication through the mouthpiece of the inhaler.

Common side effects may include throat irritation, hoarseness, dry mouth, headaches, and tremors.

It is important to discuss all your current medications with your healthcare provider to avoid potential interactions.

Store BREZTRI 4.8 ug/1 at room temperature and keep it away from moisture and heat.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.